HIV vaccines polytope (Bavarian Nordic/VaxOnco)

N/A

Report date: 2026/05/12 09:09:40

Base Information

Drug NameHIV vaccines polytope (Bavarian Nordic/VaxOnco)
Drug Alias NameMVA-BN PolytopeHIV DNA vaccine + MVA HIV vaccine - Bavarian NordicMVA-BN32EP-1233EP-1232 +[6] 
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKael-Gemvax Co LtdBavarian Nordic A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Bavarian Nordic A/S
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A